A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Clinical trial NCT01262235 · COMPLETED

Trial details

NCT number: NCT01262235
Sponsor: Arbutus Biopharma Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Neuroendocrine Tumors NET Adrenocortical Carcinoma ACC

Start date: 2010-12-01
Primary completion: 2015-07-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.